2014
DOI: 10.1007/s12017-014-8327-5
|View full text |Cite
|
Sign up to set email alerts
|

Oculopharyngeal Muscular Dystrophy: Phenotypic and Genotypic Studies in a Chinese Population

Abstract: Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant late-onset neuromuscular degenerative disease characterized by ptosis, dysphagia, and proximal muscle weakness. The genetic basis has been identified as an abnormal (GCN) expansion encoding the polyalanine tract in exon 1 of the polyadenylate-binding protein nuclear 1 gene (PABPN1). OPMD is worldwide distributed, but has rarely been reported in East Asians. In this study, we summarized the clinical and genetic characteristics of 34 individuals … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 17 publications
1
14
0
Order By: Relevance
“…Prior to this study, this important issue had not been confirmed, probably due to the relatively small size of genotyped cohorts ranging from 17 to 86 patients. 4 11 Nevertheless, it seemed that phenotypes including early onset, severe ptosis and dysphagia, proximal muscle weakness, and loss of ambulation were observed in patients with the largest PABPN1 heterozygous expansion repeats, as well as in compound heterozygous and homozygous patients. 2 , 13 , 15 , 16 Cognitive decline and psychological disorders were described in homozygous patients 17 and in 2 heterozygous patients harboring 18 expansions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior to this study, this important issue had not been confirmed, probably due to the relatively small size of genotyped cohorts ranging from 17 to 86 patients. 4 11 Nevertheless, it seemed that phenotypes including early onset, severe ptosis and dysphagia, proximal muscle weakness, and loss of ambulation were observed in patients with the largest PABPN1 heterozygous expansion repeats, as well as in compound heterozygous and homozygous patients. 2 , 13 , 15 , 16 Cognitive decline and psychological disorders were described in homozygous patients 17 and in 2 heterozygous patients harboring 18 expansions.…”
Section: Discussionmentioning
confidence: 99%
“… 2 , 3 OPMD shows a large worldwide distribution (described in more than 30 countries) and several studies describing the distribution of PABPN1 alleles on a large cohort have been published. 4 11 In these studies, no correlation between the size of the expansion and the severity of the phenotype could clearly be evidenced, probably due to the relatively small size of genotyped patient cohorts. Here we performed a retrospective analysis on the French cohort diagnosed in neuromuscular reference centers between 1999 and 2014.…”
mentioning
confidence: 83%
“…All patients were analyzed for (GCN) expansion in exon 1 of PABPN1 by polymerase chain reaction (PCR) followed by direct sequencing to exclude OPMD [ 17 ]. The CTG repeat in the 3′ region of the DMPK gene, which is causative for DM1, was assessed by triplet repeat primed PCR.…”
Section: Methodsmentioning
confidence: 99%
“…It is yet obscure whether in OPMD, alanine expansion length affects muscle weakness severity. Recent studies suggested that additional factors, other than the known genotype, could modulate disease severity [29]. Our previous studies suggested that aging factors could affect symptom initiation [27].…”
Section: Resultsmentioning
confidence: 99%